エトリコキシブ錠剤の世界市場成長 2024-2030Global Etoricoxib Tablet Market Growth 2024-2030 LPI(エルピーアイ情報)の最新調査によると、エトリコキシブ錠の世界市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、エトリコキシブ錠剤はレビュー期間中の年平均成長率(CAGR... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーLPI(エルピーアイ情報)の最新調査によると、エトリコキシブ錠の世界市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、エトリコキシブ錠剤はレビュー期間中の年平均成長率(CAGR)で2030年までに100万米ドルの再調整規模になると予測されています。この調査レポートは、世界のエトリコキシブ錠剤市場の成長可能性を明らかにしています。エトリコキシブ錠剤は今後の市場でも安定した成長が期待されます。しかし、エトリコキシブ錠剤の普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要です。市場プレーヤーは、エトリコキシブ錠剤市場が提供する膨大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを築き、進化する消費者の嗜好に合わせた製品を提供する必要があります。 エトリコキシブは、変形性関節症、関節リウマチ、強直性脊椎炎などの関節炎の炎症(腫れ)を抑え、痛みを和らげるために使用される。 主な特徴 エトリコキシブ錠剤市場に関するレポートは様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、Etoricoxib Tablet市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(例:60mg、90mg)、地域別内訳などが含まれる場合があります。 市場促進要因と課題:政府規制、環境問題、技術進歩、消費者嗜好の変化など、エトリコキシブ錠剤市場の成長を促進する要因を特定・分析することができます。また、インフラの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。 競合情勢:この調査レポートは、エトリコキシブ錠剤市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれます。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。 技術開発:調査レポートは、エトリコキシブ錠剤業界における最新の技術開発を掘り下げることができます。これには、Etoricoxib Tablet技術の進歩、Etoricoxib Tabletの新規参入、Etoricoxib Tabletの新規投資、Etoricoxib Tabletの将来を形作るその他のイノベーションなどが含まれます。 川下の事業者の好み:本レポートは、Etoricoxib Tablet市場における顧客の購買行動や採用動向を明らかにします。エトリコキシブ錠製品に対する顧客の購買決定や嗜好に影響を与える要因も含まれています。 政府の政策とインセンティブ:調査レポートは、政府の政策やインセンティブがエトリコキシブ錠剤市場に与える影響を分析します。これには、エトリコキシブ錠市場の促進を目的とした規制枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。 環境への影響と持続可能性調査レポートは、エトリコキシブ錠剤市場の環境影響と持続可能性の側面を評価します。 市場予測と将来展望:実施した分析に基づいて、調査レポートはエトリコキシブ錠剤産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を行っています。市場関係者が新たなトレンドを活用し、課題を克服し、エトリコキシブ錠剤市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場細分化: エトリコキシブ錠剤市場はタイプ別、用途別に分類しています。2019-2030年の期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。 タイプ別セグメント 60mg 90mg 120mg 用途別セグメント 変形性関節症(OA) 関節リウマチ(RA) 強直性脊椎炎 その他 本レポートではまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、一次専門家から収集したインプットと、企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 メルク アドバケア アルファドラッグス BSA Pharma Inc. Vibcare Pharma Pvt Ltd ウェローナファーマ インセプタ・ファーマシューティカルズ LXIRメディラブズ スイスケヘルスケア MKメディシン 奇瑞製薬株式会社 本レポートで扱う主な質問 世界のエトリコキシブ錠剤市場の10年見通しは? エトリコキシブ錠剤の世界市場および地域別市場成長の要因は何か? 市場別・地域別で最も急成長する技術は何か? エトリコキシブ錠剤の市場機会は最終市場規模によってどのように異なるのか? エトリコキシブ錠剤のタイプ別、用途別の内訳は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Etoricoxib Tablet Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Etoricoxib Tablet by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Etoricoxib Tablet by Country/Region, 2019, 2023 & 2030 2.2 Etoricoxib Tablet Segment by Type 2.2.1 60mg 2.2.2 90mg 2.2.3 120mg 2.3 Etoricoxib Tablet Sales by Type 2.3.1 Global Etoricoxib Tablet Sales Market Share by Type (2019-2024) 2.3.2 Global Etoricoxib Tablet Revenue and Market Share by Type (2019-2024) 2.3.3 Global Etoricoxib Tablet Sale Price by Type (2019-2024) 2.4 Etoricoxib Tablet Segment by Application 2.4.1 Osteoarthritis (OA) 2.4.2 Rheumatoid Arthritis (RA) 2.4.3 Ankylosing Spondylitis 2.4.4 Others 2.5 Etoricoxib Tablet Sales by Application 2.5.1 Global Etoricoxib Tablet Sale Market Share by Application (2019-2024) 2.5.2 Global Etoricoxib Tablet Revenue and Market Share by Application (2019-2024) 2.5.3 Global Etoricoxib Tablet Sale Price by Application (2019-2024) 3 Global Etoricoxib Tablet by Company 3.1 Global Etoricoxib Tablet Breakdown Data by Company 3.1.1 Global Etoricoxib Tablet Annual Sales by Company (2019-2024) 3.1.2 Global Etoricoxib Tablet Sales Market Share by Company (2019-2024) 3.2 Global Etoricoxib Tablet Annual Revenue by Company (2019-2024) 3.2.1 Global Etoricoxib Tablet Revenue by Company (2019-2024) 3.2.2 Global Etoricoxib Tablet Revenue Market Share by Company (2019-2024) 3.3 Global Etoricoxib Tablet Sale Price by Company 3.4 Key Manufacturers Etoricoxib Tablet Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Etoricoxib Tablet Product Location Distribution 3.4.2 Players Etoricoxib Tablet Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Etoricoxib Tablet by Geographic Region 4.1 World Historic Etoricoxib Tablet Market Size by Geographic Region (2019-2024) 4.1.1 Global Etoricoxib Tablet Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Etoricoxib Tablet Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Etoricoxib Tablet Market Size by Country/Region (2019-2024) 4.2.1 Global Etoricoxib Tablet Annual Sales by Country/Region (2019-2024) 4.2.2 Global Etoricoxib Tablet Annual Revenue by Country/Region (2019-2024) 4.3 Americas Etoricoxib Tablet Sales Growth 4.4 APAC Etoricoxib Tablet Sales Growth 4.5 Europe Etoricoxib Tablet Sales Growth 4.6 Middle East & Africa Etoricoxib Tablet Sales Growth 5 Americas 5.1 Americas Etoricoxib Tablet Sales by Country 5.1.1 Americas Etoricoxib Tablet Sales by Country (2019-2024) 5.1.2 Americas Etoricoxib Tablet Revenue by Country (2019-2024) 5.2 Americas Etoricoxib Tablet Sales by Type 5.3 Americas Etoricoxib Tablet Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Etoricoxib Tablet Sales by Region 6.1.1 APAC Etoricoxib Tablet Sales by Region (2019-2024) 6.1.2 APAC Etoricoxib Tablet Revenue by Region (2019-2024) 6.2 APAC Etoricoxib Tablet Sales by Type 6.3 APAC Etoricoxib Tablet Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Etoricoxib Tablet by Country 7.1.1 Europe Etoricoxib Tablet Sales by Country (2019-2024) 7.1.2 Europe Etoricoxib Tablet Revenue by Country (2019-2024) 7.2 Europe Etoricoxib Tablet Sales by Type 7.3 Europe Etoricoxib Tablet Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Etoricoxib Tablet by Country 8.1.1 Middle East & Africa Etoricoxib Tablet Sales by Country (2019-2024) 8.1.2 Middle East & Africa Etoricoxib Tablet Revenue by Country (2019-2024) 8.2 Middle East & Africa Etoricoxib Tablet Sales by Type 8.3 Middle East & Africa Etoricoxib Tablet Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Etoricoxib Tablet 10.3 Manufacturing Process Analysis of Etoricoxib Tablet 10.4 Industry Chain Structure of Etoricoxib Tablet 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Etoricoxib Tablet Distributors 11.3 Etoricoxib Tablet Customer 12 World Forecast Review for Etoricoxib Tablet by Geographic Region 12.1 Global Etoricoxib Tablet Market Size Forecast by Region 12.1.1 Global Etoricoxib Tablet Forecast by Region (2025-2030) 12.1.2 Global Etoricoxib Tablet Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Etoricoxib Tablet Forecast by Type 12.7 Global Etoricoxib Tablet Forecast by Application 13 Key Players Analysis 13.1 Merk 13.1.1 Merk Company Information 13.1.2 Merk Etoricoxib Tablet Product Portfolios and Specifications 13.1.3 Merk Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Merk Main Business Overview 13.1.5 Merk Latest Developments 13.2 AdvaCare 13.2.1 AdvaCare Company Information 13.2.2 AdvaCare Etoricoxib Tablet Product Portfolios and Specifications 13.2.3 AdvaCare Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 AdvaCare Main Business Overview 13.2.5 AdvaCare Latest Developments 13.3 Alpha Drugs 13.3.1 Alpha Drugs Company Information 13.3.2 Alpha Drugs Etoricoxib Tablet Product Portfolios and Specifications 13.3.3 Alpha Drugs Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Alpha Drugs Main Business Overview 13.3.5 Alpha Drugs Latest Developments 13.4 BSA Pharma Inc. 13.4.1 BSA Pharma Inc. Company Information 13.4.2 BSA Pharma Inc. Etoricoxib Tablet Product Portfolios and Specifications 13.4.3 BSA Pharma Inc. Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 BSA Pharma Inc. Main Business Overview 13.4.5 BSA Pharma Inc. Latest Developments 13.5 Vibcare Pharma Pvt Ltd 13.5.1 Vibcare Pharma Pvt Ltd Company Information 13.5.2 Vibcare Pharma Pvt Ltd Etoricoxib Tablet Product Portfolios and Specifications 13.5.3 Vibcare Pharma Pvt Ltd Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Vibcare Pharma Pvt Ltd Main Business Overview 13.5.5 Vibcare Pharma Pvt Ltd Latest Developments 13.6 WELLONA PHARMA 13.6.1 WELLONA PHARMA Company Information 13.6.2 WELLONA PHARMA Etoricoxib Tablet Product Portfolios and Specifications 13.6.3 WELLONA PHARMA Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 WELLONA PHARMA Main Business Overview 13.6.5 WELLONA PHARMA Latest Developments 13.7 Incepta Pharmaceuticals Ltd. 13.7.1 Incepta Pharmaceuticals Ltd. Company Information 13.7.2 Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Product Portfolios and Specifications 13.7.3 Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Incepta Pharmaceuticals Ltd. Main Business Overview 13.7.5 Incepta Pharmaceuticals Ltd. Latest Developments 13.8 LXIR Medilabs 13.8.1 LXIR Medilabs Company Information 13.8.2 LXIR Medilabs Etoricoxib Tablet Product Portfolios and Specifications 13.8.3 LXIR Medilabs Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 LXIR Medilabs Main Business Overview 13.8.5 LXIR Medilabs Latest Developments 13.9 Swissche Healthcare 13.9.1 Swissche Healthcare Company Information 13.9.2 Swissche Healthcare Etoricoxib Tablet Product Portfolios and Specifications 13.9.3 Swissche Healthcare Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Swissche Healthcare Main Business Overview 13.9.5 Swissche Healthcare Latest Developments 13.10 MK Medicine 13.10.1 MK Medicine Company Information 13.10.2 MK Medicine Etoricoxib Tablet Product Portfolios and Specifications 13.10.3 MK Medicine Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 MK Medicine Main Business Overview 13.10.5 MK Medicine Latest Developments 13.11 QILU PHARMACEUTICAL CO.,LTD 13.11.1 QILU PHARMACEUTICAL CO.,LTD Company Information 13.11.2 QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Product Portfolios and Specifications 13.11.3 QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 QILU PHARMACEUTICAL CO.,LTD Main Business Overview 13.11.5 QILU PHARMACEUTICAL CO.,LTD Latest Developments 14 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global Etoricoxib Tablet market size was valued at US$ million in 2023. With growing demand in downstream market, the Etoricoxib Tablet is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Etoricoxib Tablet Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Etoricoxib Tablet by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Etoricoxib Tablet by Country/Region, 2019, 2023 & 2030 2.2 Etoricoxib Tablet Segment by Type 2.2.1 60mg 2.2.2 90mg 2.2.3 120mg 2.3 Etoricoxib Tablet Sales by Type 2.3.1 Global Etoricoxib Tablet Sales Market Share by Type (2019-2024) 2.3.2 Global Etoricoxib Tablet Revenue and Market Share by Type (2019-2024) 2.3.3 Global Etoricoxib Tablet Sale Price by Type (2019-2024) 2.4 Etoricoxib Tablet Segment by Application 2.4.1 Osteoarthritis (OA) 2.4.2 Rheumatoid Arthritis (RA) 2.4.3 Ankylosing Spondylitis 2.4.4 Others 2.5 Etoricoxib Tablet Sales by Application 2.5.1 Global Etoricoxib Tablet Sale Market Share by Application (2019-2024) 2.5.2 Global Etoricoxib Tablet Revenue and Market Share by Application (2019-2024) 2.5.3 Global Etoricoxib Tablet Sale Price by Application (2019-2024) 3 Global Etoricoxib Tablet by Company 3.1 Global Etoricoxib Tablet Breakdown Data by Company 3.1.1 Global Etoricoxib Tablet Annual Sales by Company (2019-2024) 3.1.2 Global Etoricoxib Tablet Sales Market Share by Company (2019-2024) 3.2 Global Etoricoxib Tablet Annual Revenue by Company (2019-2024) 3.2.1 Global Etoricoxib Tablet Revenue by Company (2019-2024) 3.2.2 Global Etoricoxib Tablet Revenue Market Share by Company (2019-2024) 3.3 Global Etoricoxib Tablet Sale Price by Company 3.4 Key Manufacturers Etoricoxib Tablet Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Etoricoxib Tablet Product Location Distribution 3.4.2 Players Etoricoxib Tablet Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Etoricoxib Tablet by Geographic Region 4.1 World Historic Etoricoxib Tablet Market Size by Geographic Region (2019-2024) 4.1.1 Global Etoricoxib Tablet Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Etoricoxib Tablet Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Etoricoxib Tablet Market Size by Country/Region (2019-2024) 4.2.1 Global Etoricoxib Tablet Annual Sales by Country/Region (2019-2024) 4.2.2 Global Etoricoxib Tablet Annual Revenue by Country/Region (2019-2024) 4.3 Americas Etoricoxib Tablet Sales Growth 4.4 APAC Etoricoxib Tablet Sales Growth 4.5 Europe Etoricoxib Tablet Sales Growth 4.6 Middle East & Africa Etoricoxib Tablet Sales Growth 5 Americas 5.1 Americas Etoricoxib Tablet Sales by Country 5.1.1 Americas Etoricoxib Tablet Sales by Country (2019-2024) 5.1.2 Americas Etoricoxib Tablet Revenue by Country (2019-2024) 5.2 Americas Etoricoxib Tablet Sales by Type 5.3 Americas Etoricoxib Tablet Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Etoricoxib Tablet Sales by Region 6.1.1 APAC Etoricoxib Tablet Sales by Region (2019-2024) 6.1.2 APAC Etoricoxib Tablet Revenue by Region (2019-2024) 6.2 APAC Etoricoxib Tablet Sales by Type 6.3 APAC Etoricoxib Tablet Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Etoricoxib Tablet by Country 7.1.1 Europe Etoricoxib Tablet Sales by Country (2019-2024) 7.1.2 Europe Etoricoxib Tablet Revenue by Country (2019-2024) 7.2 Europe Etoricoxib Tablet Sales by Type 7.3 Europe Etoricoxib Tablet Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Etoricoxib Tablet by Country 8.1.1 Middle East & Africa Etoricoxib Tablet Sales by Country (2019-2024) 8.1.2 Middle East & Africa Etoricoxib Tablet Revenue by Country (2019-2024) 8.2 Middle East & Africa Etoricoxib Tablet Sales by Type 8.3 Middle East & Africa Etoricoxib Tablet Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Etoricoxib Tablet 10.3 Manufacturing Process Analysis of Etoricoxib Tablet 10.4 Industry Chain Structure of Etoricoxib Tablet 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Etoricoxib Tablet Distributors 11.3 Etoricoxib Tablet Customer 12 World Forecast Review for Etoricoxib Tablet by Geographic Region 12.1 Global Etoricoxib Tablet Market Size Forecast by Region 12.1.1 Global Etoricoxib Tablet Forecast by Region (2025-2030) 12.1.2 Global Etoricoxib Tablet Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Etoricoxib Tablet Forecast by Type 12.7 Global Etoricoxib Tablet Forecast by Application 13 Key Players Analysis 13.1 Merk 13.1.1 Merk Company Information 13.1.2 Merk Etoricoxib Tablet Product Portfolios and Specifications 13.1.3 Merk Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Merk Main Business Overview 13.1.5 Merk Latest Developments 13.2 AdvaCare 13.2.1 AdvaCare Company Information 13.2.2 AdvaCare Etoricoxib Tablet Product Portfolios and Specifications 13.2.3 AdvaCare Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 AdvaCare Main Business Overview 13.2.5 AdvaCare Latest Developments 13.3 Alpha Drugs 13.3.1 Alpha Drugs Company Information 13.3.2 Alpha Drugs Etoricoxib Tablet Product Portfolios and Specifications 13.3.3 Alpha Drugs Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Alpha Drugs Main Business Overview 13.3.5 Alpha Drugs Latest Developments 13.4 BSA Pharma Inc. 13.4.1 BSA Pharma Inc. Company Information 13.4.2 BSA Pharma Inc. Etoricoxib Tablet Product Portfolios and Specifications 13.4.3 BSA Pharma Inc. Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 BSA Pharma Inc. Main Business Overview 13.4.5 BSA Pharma Inc. Latest Developments 13.5 Vibcare Pharma Pvt Ltd 13.5.1 Vibcare Pharma Pvt Ltd Company Information 13.5.2 Vibcare Pharma Pvt Ltd Etoricoxib Tablet Product Portfolios and Specifications 13.5.3 Vibcare Pharma Pvt Ltd Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Vibcare Pharma Pvt Ltd Main Business Overview 13.5.5 Vibcare Pharma Pvt Ltd Latest Developments 13.6 WELLONA PHARMA 13.6.1 WELLONA PHARMA Company Information 13.6.2 WELLONA PHARMA Etoricoxib Tablet Product Portfolios and Specifications 13.6.3 WELLONA PHARMA Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 WELLONA PHARMA Main Business Overview 13.6.5 WELLONA PHARMA Latest Developments 13.7 Incepta Pharmaceuticals Ltd. 13.7.1 Incepta Pharmaceuticals Ltd. Company Information 13.7.2 Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Product Portfolios and Specifications 13.7.3 Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Incepta Pharmaceuticals Ltd. Main Business Overview 13.7.5 Incepta Pharmaceuticals Ltd. Latest Developments 13.8 LXIR Medilabs 13.8.1 LXIR Medilabs Company Information 13.8.2 LXIR Medilabs Etoricoxib Tablet Product Portfolios and Specifications 13.8.3 LXIR Medilabs Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 LXIR Medilabs Main Business Overview 13.8.5 LXIR Medilabs Latest Developments 13.9 Swissche Healthcare 13.9.1 Swissche Healthcare Company Information 13.9.2 Swissche Healthcare Etoricoxib Tablet Product Portfolios and Specifications 13.9.3 Swissche Healthcare Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Swissche Healthcare Main Business Overview 13.9.5 Swissche Healthcare Latest Developments 13.10 MK Medicine 13.10.1 MK Medicine Company Information 13.10.2 MK Medicine Etoricoxib Tablet Product Portfolios and Specifications 13.10.3 MK Medicine Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 MK Medicine Main Business Overview 13.10.5 MK Medicine Latest Developments 13.11 QILU PHARMACEUTICAL CO.,LTD 13.11.1 QILU PHARMACEUTICAL CO.,LTD Company Information 13.11.2 QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Product Portfolios and Specifications 13.11.3 QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 QILU PHARMACEUTICAL CO.,LTD Main Business Overview 13.11.5 QILU PHARMACEUTICAL CO.,LTD Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(tablet market)の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |